| Company Name: |
Suzhou Meishi Biotechnology Co., Ltd.
|
| Tel: |
1173954148q |
| Email: |
meishipharma@126.com |
| Products Intro: |
Product Name:166374-49-8
CAS:166374-49-8
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Naxifylline
CAS:166374-49-8
Package:100mg/RMB 27500;50mg/RMB 21300;25mg/RMB 16100
|
1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- manufacturers
- Naxifylline
-
- $4000.00 / 100mg
-
2024-10-28
- CAS:166374-49-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- Basic information |
| Product Name: | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- | | Synonyms: | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl-;PubChem ID: 9841075;Naxifylline;BG9719;CVT 124;CVT124;CVT-124 | | CAS: | 166374-49-8 | | MF: | C18H24N4O3 | | MW: | 344.41 | | EINECS: | | | Product Categories: | | | Mol File: | 166374-49-8.mol | ![1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- Structure](CAS/20180601/GIF/166374-49-8.gif) |
| | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- Chemical Properties |
| Boiling point | 596.1±56.0 °C(Predicted) | | density | 1.320±0.06 g/cm3(Predicted) | | pka | 8.85±0.70(Predicted) |
| | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- Usage And Synthesis |
| Uses | Treatment of edema associated with congestive heart failure. |
| | 1H-Purine-2,6-dione,3,9-dihydro-8-(1S,2R,4S,5S,6S)-3-oxatricyclo[3.2.1.02,4]oct-6-yl-1,3-dipropyl- Preparation Products And Raw materials |
|